Doklam effect? India raises concerns around Chinese firm Fosun's takeover of Gland Pharma
The deal has won the approval of the Competition Commission of India (CCI) and India`s Foreign Investment Promotion Board (FIPB) in the last few months, but some in the government have expressed concerns, the source said, declining to be named.
Aug 01, 2017, 20:14 PM IST